Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality.
Becker YLC, Boilard É, Rollet-Labelle E, Lood C, Julien AS, Abrahamowicz M, Allaeys I, Choi M, Leclerc J, Lévesque T, Urowitz M, Hanly JG, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Wallace D, Isenberg D, Rahman A, Merrill J, Gladman DD, Bruce IN, Petri M, Ginzler E, Dooley MA, Ramsey-Goldman R, Manzi S, Jönsen A, Alarcόn GS, van Vollenhoven R, Aranow C, Ruiz-Irastorza G, Lim S, Inanc M, Kalunian K, Jacobsen S, Peschken C, Kamen D, Askanase A, Buyon J, Fortin PR.
Becker YLC, et al. Among authors: julien as.
Ann Rheum Dis. 2025 Dec 12:S0003-4967(25)04533-9. doi: 10.1016/j.ard.2025.11.007. Online ahead of print.
Ann Rheum Dis. 2025.
PMID: 41390302